Strides Shasun gets shareholders nod for UK unit's divestment

Drug firm Strides Shasun has received nod from shareholders for the divestment of its UK arm Shasun Pharma Solutions Ltd (SPSL).
In the postal ballot conducted by the company, 43.77 per cent of all eligible share holders (other than the promoters) voted on the resolution of divestment of Shasun Pharma Solutions Ltd (CRAMS business), Strides Shasun said in a filing to BSE.
"89.09 per cent of the total votes polled are in favour of the resolution," it added.
Out of the institutional participation in the voting, 86.33 per cent voted in favour of the resolution while 99.97 per cent of the non-institutional participants voted in the favour of divestment, Strides Shasun said.

Shares of Strides Shasun today closed at Rs 1,090.95 on BSE, up 2.12 per cent from its previous close.